Cabergoline is an effective medication for the treatment of idiopathic hyperprolactinemia or hyperprolactinemia caused by pituitary adenomas. Patients focus on factors such as changes in its price, the variety of purchase channels, and its excellent therapeutic effects. Cabergoline has not been launched in China and is not covered by China's medical insurance. The version produced by Pfizer Inc. (USA) with a specification of 0.5mg * 8 tablets costs approximately 22 US dollars per box.
What is the Latest Price of Cabergoline in 2025?
The price of cabergoline in 2025 varies depending on the manufacturer, specification, and market supply and demand.
Price of Pfizer (USA) Version
As the developer and manufacturer of cabergoline, Pfizer Inc. (USA) has a high reputation in the market for its cabergoline products. In 2025, the cabergoline produced by this company, with a specification of 0.5mg * 8 tablets, costs about 22 US dollars per box. This price has remained relatively stable compared to previous years, reflecting the company's optimization in cost control and market strategies.
Price of SUN (India) Version
Cabergoline produced by SUN Pharmaceutical Industries Ltd. (India) has also gained favor in the market due to its affordable price. The version with the same specification (0.5mg * 8 tablets) costs only about 9 US dollars per box. This price advantage allows more patients to afford the treatment cost of cabergoline, enabling them to benefit from the efficacy of this medication. The above prices are for reference only, and patients can choose to purchase based on their own needs.
How to Purchase Cabergoline?
Since cabergoline has not been launched in China and is not included in the medical insurance catalog, patients need to purchase it through other channels. The following are several common purchase methods:
Cross-Border E-Commerce Platforms
With the rise of cross-border e-commerce, more and more patients choose to purchase cabergoline through cross-border e-commerce platforms. These platforms usually provide a wide range of product options, convenient payment methods, and fast logistics and distribution services. Patients should carefully screen merchants and products when making purchases.
International Medical Institutions or Clinics
International medical institutions or clinics are also important channels for purchasing cabergoline. These institutions usually have professional medical teams and abundant pharmaceutical resources, and can provide patients with comprehensive medical services and drug consultation. Patients can obtain professional medication guidance and prescription services through appointment consultation, telemedicine, and other methods.
Therapeutic Effects of Cabergoline
Cabergoline is a highly effective dopamine receptor agonist, and it performs excellently in the treatment of idiopathic hyperprolactinemia or hyperprolactinemia caused by pituitary adenomas.
Indications and Efficacy
Cabergoline is mainly used for the treatment of hyperprolactinemia, including those caused by idiopathic factors, pituitary adenomas, and other etiologies. Clinical studies have shown that cabergoline can significantly reduce the prolactin level in patients, restore the normal menstrual cycle, improve infertility symptoms, and reduce breast secretions.
Medication Experience and Feedback
Many patients report that after using cabergoline, the medication has relatively few side effects and good tolerability. Due to its characteristics such as long half-life and long-lasting efficacy, patients can adjust the dosage and manage the treatment more conveniently. These advantages make cabergoline the first-choice treatment option for many patients.
During the medication period, patients should pay attention to observing possible side effects and adverse reactions, and seek medical treatment in a timely manner.
